推薦產品
等級
certified reference material
形狀
liquid
特點
Snap-N-Spike®/Snap-N-Shoot®
包裝
ampule of 1 mL
製造商／商標名
Cerilliant®
濃度
1.0 mg/mL in methanol (as free base)
技術
gas chromatography (GC): suitable
liquid chromatography (LC): suitable
應用
clinical testing
形式
single component solution
儲存溫度
2-8°C
SMILES 字串
Cl.Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
InChI
1S/C19H22ClN5O.ClH/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25;/h1-3,5-7,9,15H,4,8,10-14H2;1H
InChI 密鑰
OHHDIOKRWWOXMT-UHFFFAOYSA-N
基因資訊
human ... HTR2A(3356) , HTR2C(3358) , SLC6A4(6532)
一般說明
Trazodone is a antidepressant drug sold under trade names such as Desyrel® and Oleptro® for treatment of anxiety disorder, depression, and insomnia. Trazadone, a serotonin antagonist and reuptake inhibitor (SARI), also has anti-anxiety and hypnotic effects. This certified Snap-N-Spike® solution is suitable for use in clinical toxicology, forensic analysis, or urine drug testing methods by LC-MS/MS or GC/MS.
法律資訊
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Desyrel is a registered trademark of Aziende Chimiche Riunite Angelini Francesco (A.C.R.A.F.) S.p.A.
Oleptro is a registered trademark of Angelini Pharma Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
相關產品
產品號碼
描述
訂價
訊號詞
Danger
危險分類
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
標靶器官
Eyes
儲存類別代碼
3 - Flammable liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
49.5 °F - closed cup
閃點（°C）
9.7 °C - closed cup
Arnaud Devresse et al.
Acta gastro-enterologica Belgica, 75(2), 263-265 (2012-08-09)
We present the case of a 26-year-old man with schizoid personality disorder who suffered from a very focal and transparietal necrosis of the sigmoid after an overdose of atypical neuroleptics. This is a singular, rather unknown and potentially lethal side
Deena Ababneh et al.
Birth defects research. Part B, Developmental and reproductive toxicology, 95(2), 184-193 (2012-04-25)
This study investigated the effects of a range of antidepressant drugs on the heart of gestation day 13 rat embryos in vitro. The general hypothesis was that the drugs would adversely affect the function of the embryonic heart since they
[Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression].
Marek Jarema et al.
Psychiatria polska, 45(4), 611-625 (2012-01-12)
The pharmacological properties and possible clinical use of trazodon in the treatment of depression are presented. Trazodon is the only antidepressant from the SARI (Serotonin Antagonists and Reuptake Inhibitors) group available in Poland. It has a wide pharmacodynamic profile (being
A Georgotas et al.
Pharmacotherapy, 2(5), 255-265 (1982-09-01)
Trazodone is a new antidepressant agent that was recently introduced in the United States. It has a unique pharmacological profile that is not typical of either tricyclic or monoamine oxidase inhibitor antidepressants. As such it represents a new class of
Andrea Fagiolini et al.
CNS drugs, 26(12), 1033-1049 (2012-11-30)
Trazodone is a triazolopyridine derivative that belongs to the class of serotonin receptor antagonists and reuptake inhibitors (SARIs). The drug is approved and marketed in several countries worldwide for the treatment of major depressive disorder (MDD) in adult patients. In
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務